C-erbB-2 Expression in Squamous Cell Carcinoma of the Head and Neck
Overview
Affiliations
Seventy-five squamous cell carcinomas of the head and neck were analysed for c-erbB-2 expression using immunohistochemical techniques with four different c-erbB-2 antibodies. No membrane staining was seen in any of the squamous cell carcinomas studied with any of the antibodies; however, c-erbB-2 cytoplasmic staining was seen in 60 per cent of the tumours. The significance of cytoplasmic staining is discussed and that it may possibly represent elevated c-erbB-2 expression in squamous cell carcinomas. C-erbB-2 cytoplasmic staining was also observed in 10 of 23 normal specimens obtained from the resection margin of the tumours. No correlations were found between positive c-erbB-2 cytoplasmic staining and any of the clinicopathological parameters or survival.
Warren E, Anil J, Castro P, Kemnade J, Suzuki M, Hegde M Head Neck. 2021; 43(7):1983-1994.
PMID: 33660372 PMC: 10320663. DOI: 10.1002/hed.26662.
Expression of HER-2/neu in Oral Squamous Cell Carcinoma.
Mirza S, Hadi N, Pervaiz S, Zeb Khan S, Mokeem S, Abduljabbar T Asian Pac J Cancer Prev. 2020; 21(5):1465-1470.
PMID: 32458657 PMC: 7541867. DOI: 10.31557/APJCP.2020.21.5.1465.
Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma.
Khademi B, Khademi B, Ghaderi A, Hosseini S, Niknejad N Iran J Otorhinolaryngol. 2013; 25(72):161-8.
PMID: 24303437 PMC: 3846229.
Pardis S, Sardari Y, Ashraf M, Andisheh Tadbir A, Ebrahimi H, Purshahidi S Iran J Otorhinolaryngol. 2013; 24(69):161-70.
PMID: 24303404 PMC: 3846196.
Takikita M, Xie R, Chung J, Cho H, Ylaya K, Hong S J Transl Med. 2011; 9:126.
PMID: 21801427 PMC: 3162511. DOI: 10.1186/1479-5876-9-126.